Phenylephrine Drops Match Eyelid Taping for Ptosis Insurance Qualification

Acquired blepharoptosis is a common clinical presentation characterized by a drooping upper eyelid that restricts the superior visual field and impairs daily functioning [1]. For many patients, the preferred intervention is a Müller muscle-conjunctival resection, which is a posterior-approach surgical procedure that shortens the eyelid elevators from the underside of the lid [2, 3]. Clinicians often utilize a preoperative phenylephrine test to gauge the potential for eyelid elevation, yet insurance providers typically require objective evidence of functional impairment through visual field testing. Traditionally, this documentation involves mechanical eyelid taping to simulate surgical outcomes. While topical alpha-adrenergic agonists, which are medications that stimulate specific receptors to contract the Müller muscle and lift the lid, such as oxymetazoline 0.1%, are used for non-surgical management, their role in the diagnostic workup is evolving [4, 5, 6]. A recent study evaluates whether pharmacological elevation can serve as a reliable, patient-friendly alternative to manual taping for these essential preoperative assessments.